Translational Psychiatry

Our research focuses on the pathophysiology of mental disorders, their early detection, and their prevention and treatment.

News

Grants
Grant for medical Junior Scientists awarded to Dr. Léon Franzen
Awards
Prof. Borgwardt selected as Highly Cited Researcher in 2023 once again
Events
Lübeck proud to host the Early Career Hallucination Research Network’s Meeting 2023
Events
Translational Psychiatry Retreat 2023
Publications
Basal-Forebrain Cholinergic Nuclei Alterations are Associated With Medication and Cognitive Deficits Across the Schizophrenia Spectrum
Publications
Effective-connectivity of thalamocortical interactions following d-amphetamine, LSD, and MDMA administration
01/03

Mission

We strive to improve the prediction of psychotic disorders in young high-risk patients, and investigate the neurofunctional mechanisms and efficacy of potential innovative treatments such as cannabinoids and psychedelics. We apply a variety of methods in pharmacological and clinical studies.

02/03

About us

We are an interdisciplinary team consisting of scientists and health care personnel from the fields of psychiatry, psychology, physicians/medicine, neurosurgery, neurophysiology, mathematics, and biomedical engineering. We drive innovative, translational science forward by combining our diverse set of expertise.

03/03

Research

Our research combines clinical excellence in early intervention with extensive expertise in conducting interdisciplinary research in several key areas revolving around psychotic disorders. These include their prediction, neurofunctional and cognitive mechanisms, and efficacy of potential innovative treatments. We run a variety of pharmacological, clinical, and intervention studies that will support the development of tools for individualized prediction and treatment.

Scroll to Top